Visualitza VHIO - Articles científics per autor "Kaklamani, Virginia"
Ara mostrant els elements 1-1 d 1
-
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Bidard, François-Clement; Kaklamani, Virginia; Neven, Patrick; Streich, Guillermo; Montero, Alberto J.; Forget, Frédéric; Cortés Castan, Javier (American Society of Clinical Oncology, 2022-10-01)